99
Views
8
CrossRef citations to date
0
Altmetric
Articles

Contemporary use of disease‐modifying drugs in the management of patients with early rheumatoid arthritis in Norway

, , , , &
Pages 240-245 | Accepted 07 Nov 2008, Published online: 13 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

E Gvozdenović, R Koevoets, J Langenhoff, CF Allaart & RBM Landewé. (2014) Comparison of characteristics of international and national databases for rheumatoid arthritis: a systematic literature review. Scandinavian Journal of Rheumatology 43:5, pages 349-355.
Read now
E Besada, C Nikolaissen & H Nossent. (2012) Should rheumatoid factor in rheumatoid arthritis be sent to Davy Jones’s Locker?. Scandinavian Journal of Rheumatology 41:2, pages 85-88.
Read now
A de Thurah, M Nørgaard, M Johansen & K Stengaard-Pedersen. (2010) Time to methotrexate treatment in patients with rheumatoid arthritis referred to hospital. Scandinavian Journal of Rheumatology 39:1, pages 19-25.
Read now

Articles from other publishers (5)

Brook Hadwen, Richard Yu, Ewa Cairns & Lillian Barra. (2022) Presence of Autoantibodies in Males and Females With Rheumatoid Arthritis: A Systematic Review and Metaanalysis. The Journal of Rheumatology 49:7, pages 663-671.
Crossref
Jerzy Świerkot, Bogdan Batko, Piotr Wiland, Mariusz Jędrzejewski & Marcin Stajszczyk. (2018) Methotrexate treatment for rheumatoid arthritis in Poland: Retrospective analysis of patients in routine clinical practice. Rheumatology 56:1, pages 3-9.
Crossref
Morgan Schultz, Stephanie O. Keeling, Steven J. Katz, Walter P. Maksymowych, Dean T. Eurich & Jill J. Hall. (2017) Clinical effectiveness and safety of leflunomide in inflammatory arthritis: a report from the RAPPORT database with supporting patient survey. Clinical Rheumatology 36:7, pages 1471-1478.
Crossref
Lydia Abasolo, Leticia Leon, Luis Rodriguez-Rodriguez, Aurelio Tobias, Zulema Rosales, Jose Maria Leal, Victor Castaño, Cristina Vadillo, Pilar Macarron, Oscar Fontsere & Juan Angel Jover. (2015) Safety of disease-modifying antirheumatic drugs and biologic agents for rheumatoid arthritis patients in real-life conditions. Seminars in Arthritis and Rheumatism 44:5, pages 506-513.
Crossref
C. Gaujoux-Viala, S. Paternotte, B. Combe & M. Dougados. (2012) Evidence of the symptomatic and structural efficacy of methotrexate in daily practice as the first disease-modifying drug in rheumatoid arthritis despite its suboptimal use: results from the ESPOIR early synovitis cohort. Rheumatology 51:9, pages 1648-1654.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.